Zusammenfassung
Auch aufgrund der Ausbreitung multiresistenter Erreger gewinnt eine rasche und zuverlässige mikrobiologische Diagnostik an Bedeutung. Der zeitnahe Erregernachweis und die zugehörige Empfindlichkeitsprüfung sind nicht nur entscheidende Basis zur optimalen Behandlung bei Vorliegen komplexer Resistenzmechanismen, sondern auch notwendige Voraussetzung zur Deeskalation kalkulierter Therapieregime. Somit ist die Mikrobiologie auch integraler Bestandteil von Antibiotic-Stewardship(ABS)-Programmen. Traditionelle Ansätze mikrobiologischer Diagnostik sind durch eine methodeninhärente Langsamkeit gekennzeichnet. Die Zeitspanne bis zum Vorliegen von aussagekräftigen Resultaten beträgt 48 h oder sogar länger und dies beeinflusst schließlich auch die Dauer nichtindizierter oder ungeeigneter Antibiotikatherapien. Die fortlaufende Verbesserung verfügbarer Methoden sowie die Implementierung völlig neuartiger Technologien haben in den vergangenen Jahren zu einer fundamentalen Veränderung mikrobiologischer Analytik geführt. Diese Methoden verbessern nicht nur Sensitivität und Spezifität, sondern führen auch zu einer deutlich schnelleren Verfügbarkeit von Ergebnissen. Diese neuen diagnostischen Methoden sollen hier hinsichtlich ihrer potenziellen Bedeutung für die klinische Infektiologie kritisch beleuchtet werden.
Abstract
In the light of ever increasing problems related to the emergence of multidrug-resistant bacteria, rapid microbiological diagnostics are of growing importance. Timely pathogen detection and availability of susceptibility data are essential for optimal treatment, but are even more crucial for de-escalation of broad spectrum empiric therapies. Medical microbiology is, thus, an integral part of antimicrobial stewardship programs. Traditional microbiological techniques for species identification and susceptibility testing rely on bacterial growth and are, thus, characterized by inherent slowness. Time-to-report is usually 48 h or longer, and typically delays optimization of therapeutic regimens. Constant improvement of available techniques (e. g., molecular methods) and introduction of novel methods (e. g., matrix-assisted laser desorption ionization time-of-flight [MALDI–ToF] mass spectrometry) have fundamentally changed diagnostic procedures. As a consequence, sensitivity and specificity as well as time-to-report have been dramatically improved. In this manuscript, key methodological advances in medical microbiology are discussed, emphasizing consequences for daily management of infectious disease patients.
Literatur
Shorr AF, Micek ST, Welch EC, Doherty JA, Reichley RM, Kollef MH (2011) Inappropriate antibiotic therapy in Gram-negative sepsis increases hospital length of stay. Crit Care Med 39(1):46–51
Garcia-Vazquez E, Moral-Escudero E, Hernandez-Torres A, Canteras M, Gomez J, Ruiz J (2013) What is the impact of a rapid diagnostic E‑test in the treatment of patients with Gram-negative bacteraemia? Scand J Infect Dis 45(8):623–628
Kumar A, Ellis P, Arabi Y et al (2009) Initiation of inappropriate antimicrobial therapy results in a fivefold reduction of survival in human septic shock. Chest 136(5):1237–1248
Harris PN, Ferguson JK (2012) Antibiotic therapy for inducible AmpC beta-lactamase-producing Gram-negative bacilli: what are the alternatives to carbapenems, quinolones and aminoglycosides? Int J Antimicrob Agents 40(4):297–305
Jacoby GA (2009) AmpC beta-lactamases. Clin Microbiol Rev 22(1):161–182 (Table)
Novais A, Brilhante M, Pires J, Peixe L (2015) Evaluation of the recently launched rapid carb blue kit for detection of carbapenemase-producing gram-negative bacteria. J Clin Microbiol 53(9):3105–3107
Poirel L, Nordmann P (2015) Rapidec carba NP test for rapid detection of carbapenemase producers. J Clin Microbiol 53(9):3003–3008
Matsumoto Y, Sakakihara S, Grushnikov A et al (2016) A microfluidic channel method for rapid drug-susceptibility testing of Pseudomonas aeruginosa. PLOS ONE 11(2):e0148797
Mezger A, Gullberg E, Goransson J et al (2015) A general method for rapid determination of antibiotic susceptibility and species in bacterial infections. J Clin Microbiol 53(2):425–432
Parcina M, Bartonickova L, Vojvoda V et al (2015) Performance characteristics of the new accelerate ID/AST system for antibiotic susceptibility testing of enterobacteriaceae clinical isolates, compared to IVD routine laboratory AST systems. ICAAC, San Diego
Patel R (2015) MALDI-TOF MS for the diagnosis of infectious diseases. Clin Chem 61(1):100–111
Clerc O, Prod’hom G, Vogne C, Bizzini A, Calandra T, Greub G (2013) Impact of matrix-assisted laser desorption ionization time-of-flight mass spectrometry on the clinical management of patients with Gram-negative bacteremia: a prospective observational study. Clin Infect Dis 56(8):1101–1107
Huang AM, Newton D, Kunapuli A et al (2013) Impact of rapid organism identification via matrix-assisted laser desorption/ionization time-of-flight combined with antimicrobial stewardship team intervention in adult patients with bacteremia and candidemia. Clin Infect Dis 57(9):1237–1245
Wenzler E, Goff DA, Mangino JE, Reed EE, Wehr A, Bauer KA (2016) Impact of rapid identification of Acinetobacter baumannii via matrix-assisted laser desorption ionization time-of-flight mass spectrometry combined with antimicrobial stewardship in patients with pneumonia and/or bacteremia. Diagn Microbiol Infect Dis 84(1):63–68
Nagel JL, Huang AM, Kunapuli A et al (2014) Impact of antimicrobial stewardship intervention on coagulase-negative Staphylococcus blood cultures in conjunction with rapid diagnostic testing. J Clin Microbiol 52(8):2849–2854
Martiny D, Debaugnies F, Gateff D et al (2013) Impact of rapid microbial identification directly from positive blood cultures using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry on patient management. Clin Microbiol Infect 19(12):E568–E581
Christner M, Rohde H, Wolters M, Sobottka I, Wegscheider K, Aepfelbacher M (2010) Rapid identification of bacteria from positive blood culture bottles by use of matrix-assisted laser desorption-ionization time of flight mass spectrometry fingerprinting. J Clin Microbiol 48(5):1584–1591
Burrer A, Findeisen P, Jager E et al (2015) Rapid detection of cefotaxime-resistant Escherichia coli by LC-MS. Int J Med Microbiol 305(8):860–864
Lasserre C, De Saint ML, Cuzon G et al (2015) Efficient detection of carbapenemase activity in Enterobacteriaceae by matrix-assisted laser desorption ionization-time of flight mass spectrometry in less than 30 minutes. J Clin Microbiol 53(7):2163–2171
Drancourt M, Michel-Lepage A, Boyer S, Raoult D (2016) The point-of-care laboratory in clinical microbiology. Clin Microbiol Rev 29(3):429–447
Blanc DS, Basset P, Nahimana-Tessemo I, Jaton K, Greub G, Zanetti G (2011) High proportion of wrongly identified methicillin-resistant Staphylococcus aureus carriers by use of a rapid commercial PCR assay due to presence of staphylococcal cassette chromosome element lacking the mecA gene. J Clin Microbiol 49(2):722–724
Marner ES, Wolk DM, Carr J et al (2011) Diagnostic accuracy of the Cepheid GeneXpert vanA/vanB assay ver. 1.0 to detect the vanA and vanB vancomycin resistance genes in Enterococcus from perianal specimens. Diagn Microbiol Infect Dis 69(4):382–389
Crobach MJ, Terveer EM, Kuijper EJ (2016) Effect of detecting and isolating asymptomatic Clostridium difficile carriers. JAMA Intern Med 176(10):1572–1573
Azzari C, Nieddu F, Moriondo M et al (2016) Underestimation of invasive meningococcal disease in italy. Emerging Infect Dis 22(3):469–475
Dunne EM, Mantanitobua S, Singh SP et al (2016) Real-time qPCR improves meningitis pathogen detection in invasive bacterial-vaccine preventable disease surveillance in Fiji. Sci Rep 6:39784. doi:10.1038/srep39784.:39784
Meyer T, Franke G, Polywka SK et al (2014) Improved detection of bacterial central nervous system infections by use of a broad-range PCR assay. J Clin Microbiol 52(5):1751–1753
Binnicker MJ (2015) Multiplex molecular panels for diagnosis of gastrointestinal infection: performance, result interpretation, and cost-effectiveness. J Clin Microbiol 53(12):3723–3728
Krause JC, Panning M, Hengel H, Henneke P (2014) The role of multiplex PCR in respiratory tract infections in children. Dtsch Arztebl Int 111(38):639–645
Timbrook T, Maxam M, Bosso J (2015) Antibiotic discontinuation rates associated with positive respiratory viral panel and low procalcitonin results in proven or suspected respiratory infections. Infect Dis Ther 4(3):297–306
Yee C, Suarthana E, Dendukuri N, Nicolau I, Semret M, Frenette C (2016) Evaluating the impact of the multiplex respiratory virus panel polymerase chain reaction test on the clinical management of suspected respiratory viral infections in adult patients in a hospital setting. Am J Infect Control 44(11):1396–1398
Carver PL, Lin SW, DePestel DD, Newton DW (2008) Impact of mecA gene testing and intervention by infectious disease clinical pharmacists on time to optimal antimicrobial therapy for Staphylococcus aureus bacteremia at a University Hospital. J Clin Microbiol 46(7):2381–2383
Brown J, Paladino JA (2010) Impact of rapid methicillin-resistant Staphylococcus aureus polymerase chain reaction testing on mortality and cost effectiveness in hospitalized patients with bacteraemia: a decision model. Pharmacoeconomics 28(7):567–575
Emonet S, Charles PG, Harbarth S et al (2016) Rapid molecular determination of methicillin resistance in staphylococcal bacteraemia improves early targeted antibiotic prescribing: a randomized clinical trial. Clin Microbiol Infect 27(16):10
Tuite N, Reddington K, Barry T, Zumla A, Enne V (2014) Rapid nucleic acid diagnostics for the detection of antimicrobial resistance in Gram-negative bacteria: is it time for a paradigm shift? J Antimicrob Chemother 69(7):1729–1733
Dodemont M, De MR, Nonhoff C, Roisin S, Denis O (2014) Performance of the Verigene Gram-negative blood culture assay for rapid detection of bacteria and resistance determinants. J Clin Microbiol 52(8):3085–3087
Ward C, Stocker K, Begum J, Wade P, Ebrahimsa U, Goldenberg SD (2015) Performance evaluation of the Verigene(R) (Nanosphere) and FilmArray(R) (BioFire(R)) molecular assays for identification of causative organisms in bacterial bloodstream infections. Eur J Clin Microbiol Infect Dis 34(3):487–496
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
F. P. Maurer, M. Hentschke und H. Rohde geben an, dass kein Interessenkonflikt besteht.
Dieser Beitrag beinhaltet keine von den Autoren durchgeführten Studien an Menschen oder Tieren.
Additional information
Redaktion
T. Welte, Hannover, K.-F. Bodmann, Eberswalde
Rights and permissions
About this article
Cite this article
Maurer, F.P., Hentschke, M. & Rohde, H. Neue mikrobiologische Diagnostikverfahren. Med Klin Intensivmed Notfmed 112, 199–205 (2017). https://doi.org/10.1007/s00063-017-0275-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00063-017-0275-z